Approximately 39.9 million people worldwide are living with HIV, the virus that causes AIDS, based on the most recent UNAIDS global estimates. That number has been climbing steadily, not because the epidemic is worsening, but because effective treatment is keeping people alive far longer than in previous decades. The actual number of people who have progressed to AIDS, the most advanced stage of HIV, is significantly smaller and harder to pin down, since treatment can prevent that progression entirely.
HIV vs. AIDS: Why the Numbers Differ
HIV and AIDS are not the same thing, and the distinction matters when interpreting global statistics. HIV is the virus. AIDS is a diagnosis given when the infection has severely damaged the immune system. Specifically, a person with HIV is diagnosed with AIDS if their CD4 immune cell count drops below 200 cells per cubic millimeter of blood, or if they develop certain serious infections that a healthy immune system would normally fight off. A person with an intact CD4 count above that threshold has HIV but does not have AIDS.
Most global health organizations track the number of people living with HIV rather than AIDS specifically. The reason is practical: with modern antiretroviral therapy, most people who start treatment early never progress to AIDS at all. Their immune systems stay strong enough that the AIDS diagnosis never applies. So when you see the 39.9 million figure, that includes everyone from recently diagnosed individuals with no symptoms to the smaller subset who have developed AIDS-defining conditions.
Where HIV Is Most Concentrated
Sub-Saharan Africa remains the epicenter of the global epidemic by a wide margin. The region accounts for roughly two-thirds of all people living with HIV worldwide. Women and girls are disproportionately affected there, making up 63% of all new infections in the region. Every week, about 4,000 adolescent girls and young women between ages 15 and 24 become infected with HIV globally, and 3,300 of those infections occur in sub-Saharan Africa alone.
Eastern and Southern Africa carry the heaviest burden within the continent, with countries like South Africa, Mozambique, and Nigeria accounting for a large share of cases. Outside Africa, the Asia-Pacific region has the second-largest number of people living with HIV, followed by Western and Central Europe and North America. But prevalence rates in these regions are far lower as a percentage of the population. In most high-income countries, HIV affects well under 1% of the general population, while several Southern African nations have adult prevalence rates above 10%.
New Infections and Annual Deaths
Around 1.3 million people acquired HIV in the most recent reporting year. That figure has been declining steadily. At the epidemic’s peak in the late 1990s, roughly 3.5 million people were infected each year, so new infections have dropped by more than 60% since then. Still, 1.3 million new cases a year means the global total continues to grow, since more people are being infected than are dying.
AIDS-related deaths have fallen dramatically as well. At their peak around 2004, approximately 2 million people died from AIDS-related illnesses in a single year. That number has since dropped to around 630,000 annual deaths. The decline is almost entirely due to expanded access to antiretroviral therapy, which suppresses the virus and allows the immune system to recover. In countries with strong treatment programs, AIDS-related death has become relatively uncommon.
How Treatment Changed the Math
The reason the total number of people living with HIV keeps rising while deaths fall is straightforward: treatment works. Antiretroviral therapy doesn’t cure HIV, but it controls the virus so effectively that a person diagnosed in their 20s and started on treatment promptly can expect a near-normal lifespan. That means people who would have died within a decade in the 1990s are now living with HIV for 30, 40, or more years.
Globally, about 30.7 million people are currently on antiretroviral treatment. That’s a massive expansion from just 7.7 million a decade ago. The international target, known as 95-95-95, aims for 95% of people with HIV to know their status, 95% of those diagnosed to be on treatment, and 95% of those on treatment to have the virus fully suppressed in their blood. As of recent data, the world is approaching but hasn’t yet reached those benchmarks. Roughly 86% of people living with HIV know they have it, about 77% are on treatment, and around 72% have achieved viral suppression.
Viral suppression matters for more than individual health. A person whose viral load is undetectable cannot transmit the virus sexually, a principle known as U=U (undetectable equals untransmittable). This means treatment itself is a powerful prevention tool.
Children and Mother-to-Child Transmission
An estimated 1.4 million children under 15 are living with HIV worldwide. Most acquired the virus from their mothers during pregnancy, childbirth, or breastfeeding. This type of transmission is almost entirely preventable with proper treatment. When a pregnant woman with HIV takes antiretroviral medication, the chance of passing the virus to her baby drops from about 15 to 45% down to below 1%.
Coverage of prevention programs for pregnant women has expanded significantly, reaching about 82% of pregnant women living with HIV globally. But gaps remain, particularly in West and Central Africa, where access to prenatal HIV services lags behind other regions. Children who do acquire HIV also face challenges getting onto treatment. Pediatric treatment coverage has historically been lower than adult coverage, partly because diagnosing infants requires specialized testing and child-friendly drug formulations have been slower to develop.
Why the Global Total Keeps Growing
If you’re wondering why the number of people with HIV hasn’t started shrinking, the math is simple. Each year, about 1.3 million people are newly infected while roughly 630,000 die from AIDS-related causes. That net difference of around 700,000 people adds to the global total annually. As treatment continues to extend lives and new infections continue to outpace deaths, the total population living with HIV will keep increasing for the foreseeable future.
This is, paradoxically, partly a sign of progress. More people living with HIV means fewer people dying from it. The real measure of success is the decline in new infections and deaths, both of which are on a downward trajectory. The challenge ahead is closing the remaining gaps in testing and treatment access, particularly in sub-Saharan Africa and among populations that face stigma or legal barriers to healthcare, including men who have sex with men, sex workers, people who inject drugs, and transgender individuals in many parts of the world.